Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-07-12
2011-07-12
Saeed, Kamal A (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C546S211000
Reexamination Certificate
active
07977358
ABSTRACT:
The invention is concerned with novel pyrazol derivatives of formula (I),whereinR1, R2, R3, R4, X and Y are as defined herein, as well as physiologically acceptable salts thereof. These compounds are antagonists of CCR-2 receptor and/or CCR-5 receptor and can be used as medicaments.
REFERENCES:
patent: 5134142 (1992-07-01), Matsuo et al.
patent: 2004/0220170 (2004-11-01), Atkinson et al.
patent: 2005/0020564 (2005-01-01), Atkinson et al.
patent: 2005/0176703 (2005-08-01), Gabriel et al.
patent: 2005/0192302 (2005-09-01), Xue et al.
patent: 2006/0058351 (2006-03-01), Diaz et al.
patent: 2006/0264419 (2006-11-01), Schiemann et al.
patent: 2007/0015784 (2007-01-01), Sundermann et al.
patent: 101 49 370 (2003-04-01), None
patent: 103 15 572 (2004-10-01), None
patent: 10 2004 014 296 (2005-10-01), None
patent: 10 2005 030 051 (2006-12-01), None
patent: 1762568 (2007-03-01), None
patent: 61040266 (1986-02-01), None
patent: WO 99/05823 (1999-11-01), None
patent: WO 03/004480 (2003-01-01), None
patent: WO 03/037274 (2003-05-01), None
patent: WO 03/093266 (2003-11-01), None
patent: WO 2004/047776 (2004-06-01), None
patent: WO 2005/101989 (2005-11-01), None
patent: WO 2006/089076 (2006-08-01), None
patent: WO 2007/008541 (2007-01-01), None
patent: WO 2008/075019 (2008-06-01), None
Wolff et al., Burger's Medicinal Chemistry and Drug Discovery, 1994, Wiley-Interscience, Fifth Edition, vol. I: Principles and Practice, pp. 975-977.
Witte et al., J. Org. Chem., 37, pp. 2849-2853 (1972).
Richter, R., Helvetica Chimica Acta, 35, pp. 478-485 (1952).
Jung, J., Tetrahedron, 58, pp. 3639-3646 (2002).
Stara et al., Collect. Czech. Chem. Commun., 64, pp. 649-672 (1999).
Tanaka et al., Bull. Chem. Soc. Jpn., 59, pp. 2631-2632 (1986).
Shawali et al., Tetrahedron, 29, pp. 121-124 (1973).
Mann et al., Synthesis, pp. 331-333 (1985).
Guzman-Perez et al., Bioorg. Med. Chem. Lett., 11, pp. 803-807 (2001).
Bouzard et al., J. Med. Chem., 33, pp. 1344-1352 (1990).
Rosen et al., J. Med. Chem., 31, pp. 1598-1611 (1988).
Mitsumori et al., J. Am. Chem. Soc. 129, pp. 1040-1041 (2006).
Huang et al., Tetrahedron, 54, pp. 1254712560 (1998).
Zhao et al., Heterocycles, 39, pp. 163-170 (1994).
Wysong et al., J. Org. Chem., 61, pp. 7650-7651 (1996).
Smith et al., J. Med. Chem., 38, pp. 3772-3779 (1995).
Ksander et al., J. Org. Chem., 42, pp. 1180-1185 (1977).
Machetti et al., Tetrahedron, 57, pp. 4995-4498 (2001).
Tamaki et al., J. Org. Chem., 66, pp. 3593-3596 (2001).
Taylor et al., Tetrahedron Lett., 37, pp. 1297-1300 (1996).
Palazzino et al., II Farmaco—Ed. Sc., 41, pp. 566-576 (1986).
Aebi Johannes
Binggeli Alfred
Green Luke
Hartmann Guido
Maerki Hans P.
Bianchi Kristin
Hoffmann-La Roche Inc.
Johnston George W.
Rocha-Tramaloni Patricia S.
Saeed Kamal A
LandOfFree
Pyrazol derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyrazol derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrazol derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2619782